176 related articles for article (PubMed ID: 25136636)
1. Potential smoothened inhibitor from traditional Chinese medicine against the disease of diabetes, obesity, and cancer.
Chen KC; Sun MF; Chen HY; Lee CC; Chen CY
Biomed Res Int; 2014; 2014():873010. PubMed ID: 25136636
[TBL] [Abstract][Full Text] [Related]
2. Molecular modeling study on the dynamical structural features of human smoothened receptor and binding mechanism of antagonist LY2940680 by metadynamics simulation and free energy calculation.
Bai Q; Shen Y; Jin N; Liu H; Yao X
Biochim Biophys Acta; 2014 Jul; 1840(7):2128-38. PubMed ID: 24637074
[TBL] [Abstract][Full Text] [Related]
3. Treatment of cardiovascular disease by traditional Chinese medicine against pregnane X receptor.
Chen KB; Chen HY; Chen KC; Chen CY
Biomed Res Int; 2014; 2014():950191. PubMed ID: 25050380
[TBL] [Abstract][Full Text] [Related]
4. In silico investigation of potential pyruvate kinase M2 regulators from traditional Chinese medicine against cancers.
Chen KC; Chen KB; Chen HY; Chen CY
Biomed Res Int; 2014; 2014():189495. PubMed ID: 25089263
[TBL] [Abstract][Full Text] [Related]
5. In silico investigation of potential mTOR inhibitors from traditional Chinese medicine for treatment of Leigh syndrome.
Chen KC; Lee WY; Chen HY; Chen CY
Biomed Res Int; 2014; 2014():139492. PubMed ID: 25045657
[TBL] [Abstract][Full Text] [Related]
6. In silico investigation of potential TRAF6 inhibitor from traditional Chinese medicine against cancers.
Chen KC; Lee WY; Chen HY; Chen CY
Biomed Res Int; 2014; 2014():429486. PubMed ID: 25089269
[TBL] [Abstract][Full Text] [Related]
7. Potential mitochondrial isocitrate dehydrogenase R140Q mutant inhibitor from traditional Chinese medicine against cancers.
Lee WY; Chen KC; Chen HY; Chen CY
Biomed Res Int; 2014; 2014():364625. PubMed ID: 24995286
[TBL] [Abstract][Full Text] [Related]
8. MRT-92 inhibits Hedgehog signaling by blocking overlapping binding sites in the transmembrane domain of the Smoothened receptor.
Hoch L; Faure H; Roudaut H; Schoenfelder A; Mann A; Girard N; Bihannic L; Ayrault O; Petricci E; Taddei M; Rognan D; Ruat M
FASEB J; 2015 May; 29(5):1817-29. PubMed ID: 25636740
[TBL] [Abstract][Full Text] [Related]
9. Structure of the human smoothened receptor bound to an antitumour agent.
Wang C; Wu H; Katritch V; Han GW; Huang XP; Liu W; Siu FY; Roth BL; Cherezov V; Stevens RC
Nature; 2013 May; 497(7449):338-43. PubMed ID: 23636324
[TBL] [Abstract][Full Text] [Related]
10. Three-in-one agonists for PPAR-α, PPAR-γ, and PPAR-δ from traditional Chinese medicine.
Chen KC; Chang SS; Huang HJ; Lin TL; Wu YJ; Chen CY
J Biomol Struct Dyn; 2012; 30(6):662-83. PubMed ID: 22731403
[TBL] [Abstract][Full Text] [Related]
11. Ligand-based 3D pharmacophore modeling, virtual screening, and molecular dynamic simulation of potential smoothened inhibitors.
Mohebbi A
J Mol Model; 2023 Apr; 29(5):143. PubMed ID: 37062794
[TBL] [Abstract][Full Text] [Related]
12. Discovery of potent and novel smoothened antagonists via structure-based virtual screening and biological assays.
Lu W; Zhang D; Ma H; Tian S; Zheng J; Wang Q; Luo L; Zhang X
Eur J Med Chem; 2018 Jul; 155():34-48. PubMed ID: 29857275
[TBL] [Abstract][Full Text] [Related]
13. Investigation of silent information regulator 1 (Sirt1) agonists from Traditional Chinese Medicine.
Chen KC; Jian YR; Sun MF; Chang TT; Lee CC; Chen CY
J Biomol Struct Dyn; 2013; 31(11):1207-18. PubMed ID: 23075283
[TBL] [Abstract][Full Text] [Related]
14. Triazoles bind the C-terminal domain of SMO: Illustration by docking and molecular dynamics simulations the binding between SMO and triazoles.
Liu M; Liang G; Zheng H; Zheng N; Ge H; Liu W
Life Sci; 2019 Jan; 217():222-228. PubMed ID: 30543826
[TBL] [Abstract][Full Text] [Related]
15. Deciphering structural stability and binding mechanisms of potential antagonists with smoothened protein.
Sinha N; Chowdhury S; Sarkar RR
J Biomol Struct Dyn; 2018 Aug; 36(11):2917-2937. PubMed ID: 28849750
[TBL] [Abstract][Full Text] [Related]
16. Molecular Modelling of Berberine Derivatives as Inhibitors of Human Smoothened Receptor and Hedgehog Signalling Pathway Using a Newly Developed Algorithm on Anti-Cancer Drugs.
Kaboli PJ; Bazrafkan M; Ismail P; Ling KH
Recent Pat Anticancer Drug Discov; 2017 Nov; 12(4):384-400. PubMed ID: 28969581
[TBL] [Abstract][Full Text] [Related]
17. Oxysterol binding to the extracellular domain of Smoothened in Hedgehog signaling.
Nedelcu D; Liu J; Xu Y; Jao C; Salic A
Nat Chem Biol; 2013 Sep; 9(9):557-64. PubMed ID: 23831757
[TBL] [Abstract][Full Text] [Related]
18. Overcoming the emerging drug resistance of smoothened: an overview of small-molecule SMO antagonists with antiresistance activity.
Zhang H; Sun Z; Liu Z; Song C
Future Med Chem; 2018 Dec; 10(24):2855-2875. PubMed ID: 30557039
[TBL] [Abstract][Full Text] [Related]
19. Identification of potent EGFR inhibitors from TCM Database@Taiwan.
Yang SC; Chang SS; Chen HY; Chen CY
PLoS Comput Biol; 2011 Oct; 7(10):e1002189. PubMed ID: 22022246
[TBL] [Abstract][Full Text] [Related]
20. Structural basis for Smoothened receptor modulation and chemoresistance to anticancer drugs.
Wang C; Wu H; Evron T; Vardy E; Han GW; Huang XP; Hufeisen SJ; Mangano TJ; Urban DJ; Katritch V; Cherezov V; Caron MG; Roth BL; Stevens RC
Nat Commun; 2014 Jul; 5():4355. PubMed ID: 25008467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
